Two Differently Regulated Nuclear Factor κ B Activation Pathways Triggered by the Cytoplasmic Tail of CD40
CD40 signaling modulates the immune response at least in part by activation of nuclear factor κ B (NFκ B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκ B. Although four members of the tumor necrosis factor receptor...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 96; no. 4; pp. 1234 - 1239 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
National Academy of Sciences of the United States of America
16.02.1999
National Acad Sciences The National Academy of Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | CD40 signaling modulates the immune response at least in part by activation of nuclear factor κ B (NFκ B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκ B. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκ B activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκ B activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκ B activation by cyt-C is inhibited by a kinase-negative form of NFκ B-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκ B activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκ B-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκ B activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner. |
---|---|
AbstractList | CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκB. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκB activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκB activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκB activation by cyt-C is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκB activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκB activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner. tumor necrosis factor receptor-associated factor nuclear factor κB-inducing kinase protein–protein interaction CD40 signaling modulates the immune response at least in part by activation of nuclear factor Kappa B (NF Kappa B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NF Kappa B. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NF Kappa B activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NF Kappa B activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NF Kappa B activation by cyt-C is inhibited by a kinase-negative form of NF Kappa B-inducing kinase more efficiently than that by cyt-N, consistent with the result that NF Kappa B activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NF Kappa B-inducing kinase more efficiently than that by TRAF6. These results indicate that NF Kappa B activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner. CD40 signaling modulates the immune response at least in part by activation of nuclear factor κ B (NFκ B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκ B. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκ B activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκ B activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκ B activation by cyt-C is inhibited by a kinase-negative form of NFκ B-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκ B activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκ B-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκ B activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner. CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκB. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκB activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκB activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκB activation by cyt-C is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκB activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκB activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner. CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκB. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκB activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκB activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκB activation by cyt-C is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκB activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκB activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner. |
Author | Tsukamoto, Nobuo Kobayashi, Norihiko Inoue, Jun-ichiro Azuma, Sakura Yamamoto, Tadashi |
AuthorAffiliation | Department of Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan |
AuthorAffiliation_xml | – name: Department of Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan |
Author_xml | – sequence: 1 givenname: Nobuo surname: Tsukamoto fullname: Tsukamoto, Nobuo – sequence: 2 givenname: Norihiko surname: Kobayashi fullname: Kobayashi, Norihiko – sequence: 3 givenname: Sakura surname: Azuma fullname: Azuma, Sakura – sequence: 4 givenname: Tadashi surname: Yamamoto fullname: Yamamoto, Tadashi – sequence: 5 givenname: Jun-ichiro surname: Inoue fullname: Inoue, Jun-ichiro |
BookMark | eNp9kc1uEzEUhS1UVNLClgUSklfsJthjjx1LbEpKAakChMLacjx3EhdnHGxPy7waD9FnqkPaSCDByrLP-Xx_zgk66kMPCD2nZEqJZK-3vUlTJaZ8SmvGH6EJJYpWgityhCaE1LKa8Zo_QScpXRFCVDMjx-hYKVUucoK-L24CPnddBxH67Ef8FVaDNxla_GmwHkzEF8bmEPHtL_wWn9nsrk12ocdfTF7fmDHhRXSrVcFbvBxxXgOejzlsvUkbZ_HCOI9Dh-fnnDxFjzvjEzy7P0_Rt4t3i_mH6vLz-4_zs8vKMsVy1TaKcMsMlYpYQTprFVGsbmVLO5CCNCApo8sl1BYoSCs4dHVbC9Y2wGph2Sl6s_93Oyw30NoyWDReb6PbmDjqYJz-U-ndWq_CtaYN56Lgr-7xGH4MkLLeuGTBe9NDGJKmkgrBKC_G6d5oY0gpQncoQYnehaN34WglNNe7cArA_wKsy7-3Wdpw_t_YQ0O794caB113g_cZfuZifPk_Y9Ff7PWrVBI9GLiks4bdAQpTt5g |
CitedBy_id | crossref_primary_10_1002_pro_70004 crossref_primary_10_1128_JVI_02542_06 crossref_primary_10_4049_jimmunol_173_5_2913 crossref_primary_10_1074_jbc_M109889200 crossref_primary_10_4049_jimmunol_167_11_6388 crossref_primary_10_1111_j_1349_7006_2007_00389_x crossref_primary_10_1083_jcb_201003087 crossref_primary_10_1016_j_gene_2005_05_016 crossref_primary_10_1089_ars_2007_1631 crossref_primary_10_3389_fimmu_2023_1214095 crossref_primary_10_1007_s00774_012_0353_5 crossref_primary_10_1016_j_clml_2012_01_006 crossref_primary_10_1111_j_1600_065X_2011_01055_x crossref_primary_10_1038_s41417_018_0038_x crossref_primary_10_2183_pjab_97_009 crossref_primary_10_4049_jimmunol_1302643 crossref_primary_10_1177_030089160208800502 crossref_primary_10_1152_ajprenal_00317_2004 crossref_primary_10_1091_mbc_e02_07_0378 crossref_primary_10_1038_sj_emboj_7600564 crossref_primary_10_1074_jbc_M300720200 crossref_primary_10_1080_10428190290033288 crossref_primary_10_4049_jimmunol_0900528 crossref_primary_10_1084_jem_20091293 crossref_primary_10_3892_ol_2018_9849 crossref_primary_10_1046_j_1365_2567_2000_00061_x crossref_primary_10_1002__SICI_1521_4141_199912_29_12_3908__AID_IMMU3908_3_0_CO_2_E crossref_primary_10_3389_fimmu_2019_00222 crossref_primary_10_1093_intimm_dxp013 crossref_primary_10_1016_j_molimm_2007_06_161 crossref_primary_10_1152_ajpheart_00750_2005 crossref_primary_10_1073_pnas_98_4_1751 crossref_primary_10_1096_fj_08_124545 crossref_primary_10_1016_S0898_6568_02_00083_9 crossref_primary_10_1074_jbc_M104994200 crossref_primary_10_1007_s10735_014_9575_2 crossref_primary_10_1128_JVI_77_2_1316_1328_2003 crossref_primary_10_1046_j_1365_2567_2001_01162_x crossref_primary_10_1128_JVI_76_9_4567_4579_2002 crossref_primary_10_1002_eji_200737828 crossref_primary_10_1097_00062752_200307000_00004 crossref_primary_10_4049_jimmunol_1201646 crossref_primary_10_1074_jbc_274_52_37251 crossref_primary_10_1016_S1074_7613_00_80113_2 crossref_primary_10_1038_s41598_019_57293_y crossref_primary_10_1074_jbc_275_13_9501 crossref_primary_10_1002_pro_4429 crossref_primary_10_1074_jbc_M310969200 crossref_primary_10_1038_cddis_2014_172 crossref_primary_10_1007_BF02256091 crossref_primary_10_1002_2211_5463_12211 crossref_primary_10_1074_jbc_M000531200 crossref_primary_10_1016_j_oraloncology_2006_12_008 crossref_primary_10_1074_jbc_274_42_30202 crossref_primary_10_1093_intimm_14_3_319 crossref_primary_10_1111_j_1365_2443_2010_01474_x crossref_primary_10_1074_jbc_M109250200 crossref_primary_10_1038_ni792 crossref_primary_10_1097_00130832_200212000_00003 crossref_primary_10_1016_j_pharmthera_2020_107709 crossref_primary_10_3389_fcell_2020_624985 crossref_primary_10_1189_jlb_0313157 crossref_primary_10_1128_MCB_25_22_9806_9819_2005 crossref_primary_10_1073_pnas_052247099 crossref_primary_10_1016_S1074_7613_02_00394_1 crossref_primary_10_1074_jbc_274_32_22414 crossref_primary_10_1006_excr_1999_4733 crossref_primary_10_1074_jbc_M110_118877 crossref_primary_10_1002_eji_200526219 crossref_primary_10_1002_eji_201646294 crossref_primary_10_1006_mthe_2002_0693 crossref_primary_10_1016_j_molimm_2010_08_011 crossref_primary_10_1128_MCB_20_15_5503_5515_2000 crossref_primary_10_1161_01_CIR_0000083718_76889_D0 |
Cites_doi | 10.1002/eji.1830200819 10.1016/0092-8674(95)90489-1 10.1128/MCB.16.12.7098 10.1126/science.8171316 10.1101/gad.10.8.963 10.1038/385540a0 10.1038/383443a0 10.1073/pnas.95.7.3537 10.1073/pnas.93.18.9437 10.1016/0092-8674(84)90472-0 10.1111/j.1600-065X.1994.tb00845.x 10.1016/0014-5793(94)01406-Q 10.1084/jem.182.5.1557 10.4049/jimmunol.155.12.5527 10.4049/jimmunol.148.2.620 10.1073/pnas.93.18.9699 10.1038/30996 10.1038/31002 10.1084/jem.169.6.2043 10.1038/357080a0 10.4049/jimmunol.153.10.4357 10.1084/jem.179.2.673 10.1074/jbc.271.46.28745 10.1084/jem.179.6.1923 10.1126/science.7533327 10.1002/j.1460-2075.1989.tb03521.x 10.1016/S0021-9258(18)43772-6 10.1021/bi981067q 10.1073/pnas.94.18.9792 10.1002/eji.1830221112 10.1073/pnas.89.12.5206 10.1073/pnas.82.2.488 10.1038/30989 10.1016/0092-8674(94)90532-0 10.1084/jem.187.2.237 10.1084/jem.172.6.1861 10.1038/364645a0 10.4049/jimmunol.146.6.1722 10.1016/S0021-9258(19)47397-3 10.1084/jem.177.4.925 10.1002/eji.1830260517 10.1074/jbc.271.22.12852 |
ContentType | Journal Article |
Copyright | Copyright 1993-1999 The National Academy of Sciences of the United States of America Copyright © 1999, The National Academy of Sciences 1999 |
Copyright_xml | – notice: Copyright 1993-1999 The National Academy of Sciences of the United States of America – notice: Copyright © 1999, The National Academy of Sciences 1999 |
DBID | AAYXX CITATION 7T5 7TM H94 5PM |
DOI | 10.1073/pnas.96.4.1234 |
DatabaseName | CrossRef Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Nucleic Acids Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 1239 |
ExternalDocumentID | PMC15446 10_1073_pnas_96_4_1234 96_4_1234 47185 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29P 2AX 2FS 2WC 3O- 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE AAYJJ ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACHIC ACIWK ACNCT ACPRK ADQXQ ADULT ADXHL AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM AS~ BKOMP CS3 D0L DCCCD DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HGD HH5 HQ3 HTVGU HYE IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST KQ8 L7B LU7 MVM N9A NEJ NHB N~3 O9- OK1 P-O PNE PQQKQ R.V RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VOH W8F WH7 WHG WOQ WOW X7M XSW Y6R YBH YKV YSK ZCA ZCG ~02 ~KM - 02 08R 0R 1AW 55 AAPBV ABFLS ABPTK ADACO ADZLD AFDAS AJYGW AS ASUFR DNJUQ DOOOF DWIUU DZ F20 GJ JSODD KM OHM PQEST RHF VQA X XFK XHC ZA5 AAYXX CITATION 7T5 7TM H94 5PM |
ID | FETCH-LOGICAL-c393t-d5904c3a1790c60fcc90932d7d1fe7605e7131bbe2ce1e7c64ef2d263d5e326c3 |
ISSN | 0027-8424 |
IngestDate | Thu Aug 21 13:21:52 EDT 2025 Fri Jul 11 09:44:16 EDT 2025 Thu Apr 24 23:00:32 EDT 2025 Tue Jul 01 00:46:48 EDT 2025 Thu May 30 08:52:18 EDT 2019 Wed Nov 11 00:29:57 EST 2020 Thu May 29 08:40:54 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c393t-d5904c3a1790c60fcc90932d7d1fe7605e7131bbe2ce1e7c64ef2d263d5e326c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 To whom reprint requests should be addressed at: Department of Oncology The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. e-mail: jinoue@ims.u-tokyo.ac.jp. Communicated by Inder M. Verma, The Salk Institute for Biological Studies, San Diego, CA |
PMID | 9990007 |
PQID | 17166314 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | pnas_primary_96_4_1234 proquest_miscellaneous_17166314 jstor_primary_47185 pubmedcentral_primary_oai_pubmedcentral_nih_gov_15446 crossref_citationtrail_10_1073_pnas_96_4_1234 pnas_primary_96_4_1234_fulltext crossref_primary_10_1073_pnas_96_4_1234 |
ProviderPackageCode | RNA PNE CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 19990216 1999-02-16 |
PublicationDateYYYYMMDD | 1999-02-16 |
PublicationDate_xml | – month: 2 year: 1999 text: 19990216 day: 16 |
PublicationDecade | 1990 |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationYear | 1999 |
Publisher | National Academy of Sciences of the United States of America National Acad Sciences The National Academy of Sciences |
Publisher_xml | – name: National Academy of Sciences of the United States of America – name: National Acad Sciences – name: The National Academy of Sciences |
References | Ishida T (e_1_3_3_20_2) 1995; 155 Bjorck P (e_1_3_3_16_2) 1993; 78 Torres R M (e_1_3_3_30_2) 1992; 148 Berberich I (e_1_3_3_14_2) 1994; 153 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_35_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_40_2 Barrett T B (e_1_3_3_17_2) 1991; 146 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_43_2 e_1_3_3_1_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_41_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 |
References_xml | – ident: e_1_3_3_29_2 doi: 10.1002/eji.1830200819 – ident: e_1_3_3_24_2 doi: 10.1016/0092-8674(95)90489-1 – ident: e_1_3_3_36_2 doi: 10.1128/MCB.16.12.7098 – ident: e_1_3_3_1_2 doi: 10.1126/science.8171316 – volume: 78 start-page: 218 year: 1993 ident: e_1_3_3_16_2 publication-title: Immunology – ident: e_1_3_3_28_2 doi: 10.1101/gad.10.8.963 – ident: e_1_3_3_31_2 doi: 10.1038/385540a0 – ident: e_1_3_3_39_2 doi: 10.1038/383443a0 – ident: e_1_3_3_41_2 doi: 10.1073/pnas.95.7.3537 – ident: e_1_3_3_26_2 doi: 10.1073/pnas.93.18.9437 – ident: e_1_3_3_34_2 doi: 10.1016/0092-8674(84)90472-0 – ident: e_1_3_3_43_2 doi: 10.1111/j.1600-065X.1994.tb00845.x – ident: e_1_3_3_25_2 doi: 10.1016/0014-5793(94)01406-Q – ident: e_1_3_3_18_2 doi: 10.1084/jem.182.5.1557 – volume: 155 start-page: 5527 year: 1995 ident: e_1_3_3_20_2 publication-title: J Immunol doi: 10.4049/jimmunol.155.12.5527 – volume: 148 start-page: 620 year: 1992 ident: e_1_3_3_30_2 publication-title: J Immunol doi: 10.4049/jimmunol.148.2.620 – ident: e_1_3_3_38_2 doi: 10.1073/pnas.93.18.9699 – ident: e_1_3_3_9_2 doi: 10.1038/30996 – ident: e_1_3_3_10_2 doi: 10.1038/31002 – ident: e_1_3_3_3_2 doi: 10.1084/jem.169.6.2043 – ident: e_1_3_3_4_2 doi: 10.1038/357080a0 – volume: 153 start-page: 4357 year: 1994 ident: e_1_3_3_14_2 publication-title: J Immunol doi: 10.4049/jimmunol.153.10.4357 – ident: e_1_3_3_13_2 doi: 10.1084/jem.179.2.673 – ident: e_1_3_3_27_2 doi: 10.1074/jbc.271.46.28745 – ident: e_1_3_3_12_2 doi: 10.1084/jem.179.6.1923 – ident: e_1_3_3_23_2 doi: 10.1126/science.7533327 – ident: e_1_3_3_2_2 doi: 10.1002/j.1460-2075.1989.tb03521.x – ident: e_1_3_3_22_2 doi: 10.1016/S0021-9258(18)43772-6 – ident: e_1_3_3_35_2 doi: 10.1021/bi981067q – ident: e_1_3_3_40_2 doi: 10.1073/pnas.94.18.9792 – ident: e_1_3_3_7_2 doi: 10.1002/eji.1830221112 – ident: e_1_3_3_33_2 doi: 10.1073/pnas.89.12.5206 – ident: e_1_3_3_32_2 doi: 10.1073/pnas.82.2.488 – ident: e_1_3_3_8_2 doi: 10.1038/30989 – ident: e_1_3_3_21_2 doi: 10.1016/0092-8674(94)90532-0 – ident: e_1_3_3_42_2 doi: 10.1084/jem.187.2.237 – ident: e_1_3_3_6_2 doi: 10.1084/jem.172.6.1861 – ident: e_1_3_3_5_2 doi: 10.1038/364645a0 – volume: 146 start-page: 1722 year: 1991 ident: e_1_3_3_17_2 publication-title: J Immunol doi: 10.4049/jimmunol.146.6.1722 – ident: e_1_3_3_11_2 doi: 10.1016/S0021-9258(19)47397-3 – ident: e_1_3_3_15_2 doi: 10.1084/jem.177.4.925 – ident: e_1_3_3_19_2 doi: 10.1002/eji.1830260517 – ident: e_1_3_3_37_2 doi: 10.1074/jbc.271.22.12852 |
SSID | ssj0009580 |
Score | 1.9085736 |
Snippet | CD40 signaling modulates the immune response at least in part by activation of nuclear factor κ B (NFκ B). It has been shown that two distinct domains in the... CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the... CD40 signaling modulates the immune response at least in part by activation of nuclear factor Kappa B (NF Kappa B). It has been shown that two distinct domains... CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the... |
SourceID | pubmedcentral proquest crossref pnas jstor |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 1234 |
SubjectTerms | Antibodies B lymphocytes Biochemistry Biological Sciences Cell extracts Gels Genetic mutation Physiological regulation Plasmids Proteins T lymphocytes |
Title | Two Differently Regulated Nuclear Factor κ B Activation Pathways Triggered by the Cytoplasmic Tail of CD40 |
URI | https://www.jstor.org/stable/47185 http://www.pnas.org/content/96/4/1234.abstract https://www.proquest.com/docview/17166314 https://pubmed.ncbi.nlm.nih.gov/PMC15446 |
Volume | 96 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbpswFLayTpN6M63dqmW_vli1TREsgIFwmWSdqkmNcpFK3RUyxjRZGogSUJU-2h5ib7H32DE2BqRs2nqDEjAQOF_Oj33OdxB6RynpDyIXtF-S9CFAsSwj4BYxEj9iNuVeP6GiUPhi4p1fkq9X7lWn86uRtVTkkcnu9taV3EeqsA_kKqpk_0Oy-qKwAz6DfGELEobtv8n4NtMdTvKbXW8jG8uXK_pM9INQ7XR6p-Oz09FwVDJnyDlYQag6v6W7bS-H-PxadOwsPVFADdvl2RqcapE1L_JLy4yNz5LuqPJjp9rubassg0k1rTisi1SU5tj2jN50Urc8nm2LJQWMZHLlKCoyrfdBvexEfye1prSYL5b64PCuWFE5jb0sNtqefKMrfbEZjcXZ9VyG5D-wDVlqaVbVcH_7sU1FbgO8iCy_NrnU3eD6GB6R3Ucr5S7b5SoQk4amBotNGlYfvgZ7LQqoQNEGOaVbM_BMYlbnNeC1XpX4gucRHldtWHW64_RiLEiPvAfooQ3RjF3ajyY39EBWSqlnqrhFfedT-76H6JG6ScuLkom0gp0XRrcipXaeb8Nxmj1Bj1XEg4cSvkeow9NjdFS9bPxBEZ9_fIq-A55xA89Y4xkrPGOJZ_zzxwjXWMYVlrHGMo52GECJG1jGAss4S7DA8jN0-eVsNj43VC8QgzmBkxuxG_QJc6gglGOgQRgL-hB6xH5sJdyHmJz7lmNFEbcZt7jPPMITO7Y9J3Y5RCjMOUEHaZby5wgPLCf2Ek4GzLFIEpHI5nBeEPGBb8XU6XeRUb3bkCmifNGv5SYsEzZ8JxTvOQy8kIRCKl30Xo9fS4qYP448LkWlhwnP0O2ik3JYtbMx_O3-A2GiEsPECCXsEMyCWOujKc-KbShYsDx4vi5yWxjQFxO08u0j6WJe0suXUH1xz_NeosP6j_0KHeSbgr8Gtz2P3pSg_w2YEvag |
linkProvider | ABC ChemistRy |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Two+differently+regulated+nuclear+factor+%CE%BAB+activation+pathways+triggered+by+the+cytoplasmic+tail+of+CD40&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Tsukamoto%2C+Nobuo&rft.au=Kobayashi%2C+Norihiko&rft.au=Azuma%2C+Sakura&rft.au=Yamamoto%2C+Tadashi&rft.date=1999-02-16&rft.pub=The+National+Academy+of+Sciences&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=96&rft.issue=4&rft.spage=1234&rft.epage=1239&rft_id=info:doi/10.1073%2Fpnas.96.4.1234&rft_id=info%3Apmid%2F9990007&rft.externalDocID=PMC15446 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F96%2F4.cover.gif |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F96%2F4.cover.gif |